FAQ

Frequently Asked Questions

Semaglutide and Tirzepatide are medications used to help manage blood sugar levels in individuals with type 2 diabetes and are also known for their potential benefits in weight management.
Both medications work by mimicking hormones that regulate blood sugar, helping the body manage glucose levels more effectively and promoting a feeling of fullness, which can aid in weight loss.
These medications are typically administered via injection.
Semaglutide is generally administered once weekly, while Tirzepatide dosage frequency depends on your treatment plan.
Results can vary, but many users report improvements in blood sugar levels within a few weeks. Weight loss results may take several months.
Yes, both Semaglutide and Tirzepatide have been shown to support weight loss even in individuals without diabetes.
Both medications have been studied for long-term safety, but individual risks vary. Discuss with your healthcare provider to ensure it is safe based on your health profile.
These medications may not be suitable for individuals with a history of certain thyroid conditions, pancreatitis, or severe gastrointestinal disorders. Consult your healthcare provider for a complete assessment.
While no specific diet is required, a balanced, healthy diet can improve the effectiveness of the medications for weight loss and blood sugar management.
Store both medications in the refrigerator and protect them from light. They should not be frozen.